TCW Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.77M | Buy |
27,059
+699
| +3% | +$97.9K | 0.03% | 214 |
|
|
2025
Q4 | $3.24M | Buy |
+26,360
| New | +$3.2M | 0.02% | 225 |
|
|
2025
Q3 | – | Sell |
-25,794
| Closed | -$2.86M | – | 288 |
|
|
2025
Q2 | $2.86M | Buy |
25,794
+393
| +2% | +$41.8K | 0.02% | 229 |
|
|
2025
Q1 | $2.85M | Sell |
25,401
-4,876
| -16% | -$503K | 0.03% | 221 |
|
|
2024
Q4 | $2.8M | Buy |
30,277
+343
| +1% | +$30.9K | 0.02% | 231 |
|
|
2024
Q3 | $2.51M | Sell |
29,934
-148,669
| -83% | -$11.3M | 0.02% | 239 |
|
|
2024
Q2 | $12.3M | Sell |
178,603
-381,108
| -68% | -$25.4M | 0.11% | 120 |
|
|
2024
Q1 | $41M | Buy |
559,711
+4,578
| +0.8% | +$352K | 0.42% | 59 |
|
|
2023
Q4 | $45M | Buy |
555,133
+2,852
| +0.5% | +$222K | 0.5% | 57 |
|
|
2023
Q3 | $41.4M | Sell |
552,281
-132,753
| -19% | -$10.2M | 0.52% | 55 |
|
|
2023
Q2 | $52.8M | Buy |
685,034
+79,757
| +13% | +$6.36M | 0.59% | 51 |
|
|
2023
Q1 | $50.2M | Buy |
605,277
+25,873
| +4% | +$2.14M | 0.64% | 49 |
|
|
2022
Q4 | $49.7M | Buy |
579,404
+10,298
| +2% | +$816K | 0.71% | 46 |
|
|
2022
Q3 | $35.1M | Buy |
569,106
+66,089
| +13% | +$4.17M | 0.51% | 54 |
|
|
2022
Q2 | $31.1M | Sell |
503,017
-122,282
| -20% | -$7.57M | 0.41% | 64 |
|
|
2022
Q1 | $37.2M | Sell |
625,299
-73,846
| -11% | -$4.72M | 0.35% | 76 |
|
|
2021
Q4 | $50.8M | Buy |
699,145
+25,768
| +4% | +$1.77M | 0.42% | 63 |
|
|
2021
Q3 | $47K | Sell |
673,377
-6,725
| -1% | -$472K | 0.12% | 63 |
|
|
2021
Q2 | $46.8M | Sell |
680,102
-47,332
| -7% | -$3.16M | 0.41% | 60 |
|
|
2021
Q1 | $47M | Sell |
727,434
-44,829
| -6% | -$2.89M | 0.45% | 61 |
|
|
2020
Q4 | $45M | Sell |
772,263
-47,824
| -6% | -$2.89M | 0.39% | 62 |
|
|
2020
Q3 | $51.8M | Sell |
820,087
-6,350
| -0.8% | -$440K | 0.57% | 46 |
|
|
2020
Q2 | $63.6M | Sell |
826,437
-122,749
| -13% | -$9.41M | 0.74% | 35 |
|
|
2020
Q1 | $71M | Sell |
949,186
-119,504
| -11% | -$8.26M | 0.98% | 30 |
|
|
2019
Q4 | $69.4M | Sell |
1,068,690
-90,371
| -8% | -$5.89M | 0.77% | 41 |
|
|
2019
Q3 | $73.5M | Sell |
1,159,061
-144,140
| -11% | -$9.42M | 0.84% | 41 |
|
|
2019
Q2 | $88M | Sell |
1,303,201
-537,453
| -29% | -$35.4M | 0.94% | 36 |
|
|
2019
Q1 | $120M | Sell |
1,840,654
-98,326
| -5% | -$6.54M | 1.15% | 26 |
|
|
2018
Q4 | $121M | Sell |
1,938,980
-118,409
| -6% | -$8.28M | 1.25% | 22 |
|
|
2018
Q3 | $159M | Sell |
2,057,389
-268,717
| -12% | -$20.3M | 1.3% | 22 |
|
|
2018
Q2 | $165M | Sell |
2,326,106
-13,888
| -0.6% | -$981K | 1.34% | 18 |
|
|
2018
Q1 | $176M | Buy |
2,339,994
+67,019
| +3% | +$5.33M | 1.43% | 14 |
|
|
2017
Q4 | $163M | Sell |
2,272,975
-87,543
| -4% | -$6.65M | 1.31% | 22 |
|
|
2017
Q3 | $191M | Buy |
2,360,518
+262,162
| +12% | +$20M | 1.52% | 16 |
|
|
2017
Q2 | $149M | Buy |
2,098,356
+85,448
| +4% | +$5.69M | 1.23% | 28 |
|
|
2017
Q1 | $137M | Sell |
2,012,908
-169,017
| -8% | -$11.9M | 1.14% | 31 |
|
|
2016
Q4 | $156M | Buy |
2,181,925
+518,111
| +31% | +$38.5M | 1.18% | 25 |
|
|
2016
Q3 | $132M | Buy |
1,663,814
+216,967
| +15% | +$17.6M | 1% | 36 |
|
|
2016
Q2 | $121M | Buy |
1,446,847
+187,430
| +15% | +$16.6M | 0.91% | 43 |
|
|
2016
Q1 | $116M | Buy |
1,259,417
+262,335
| +26% | +$23.7M | 0.85% | 51 |
|
|
2015
Q4 | $101M | Buy |
997,082
+14,274
| +1% | +$1.49M | 0.72% | 54 |
|
|
2015
Q3 | $96.5M | Buy |
982,808
+237,083
| +32% | +$26.3M | 0.69% | 58 |
|
|
2015
Q2 | $87.3M | Buy |
745,725
+312,954
| +72% | +$34.2M | 0.56% | 69 |
|
|
2015
Q1 | $42.5M | Buy |
432,771
+10,521
| +2% | +$1.07M | 0.2% | 118 |
|
|
2014
Q4 | $39.8M | Sell |
422,250
-318,250
| -43% | -$32.9M | 0.17% | 122 |
|
|
2014
Q3 | $78.8M | Sell |
740,500
-28,850
| -4% | -$2.82M | 0.32% | 90 |
|
|
2014
Q2 | $63.8M | Buy |
769,350
+5,050
| +0.7% | +$393K | 0.26% | 93 |
|
|
2014
Q1 | $54.2M | Buy |
764,300
+6,150
| +0.8% | +$482K | 0.22% | 98 |
|
|
2013
Q4 | $57M | Buy |
758,150
+2,350
| +0.3% | +$164K | 0.24% | 97 |
|
|
2013
Q3 | $47.5M | Buy |
755,800
+7,796
| +1% | +$466K | 0.22% | 100 |
|
|
2013
Q2 | $38.3M | Buy |
+748,004
| New | +$39M | 0.19% | 106 |
|
Other funds holding GILD
VCM
VPM
TCW Group's GILD Position: Q1 2026 in Review
TCW Group increased its Gilead Sciences (GILD) stake by 2.7% in Q1 2026, buying an estimated $97.9K and bringing the position to 27,059 shares worth $3.77M. The position accounts for 0.03% of the portfolio, ranked #214.
TCW Group first reported a position in GILD in Q2 2013 and has held it in 51 quarters since. The position peaked at $191M in Q3 2017. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- TCW Group held 27,059 shares of Gilead Sciences worth $3.77M as of Q1 2026.
- TCW Group bought 699 Gilead Sciences shares in Q1 2026, an estimated $97.9K.
- Gilead Sciences made up 0.03% of TCW Group's portfolio in Q1 2026, its #214 holding.
- TCW Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 51 quarters since.
- TCW Group's Gilead Sciences position peaked at $191M in Q3 2017.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on TCW Group's 13F filing for Q1 2026, filed 14 May 2026.